Log in

NASDAQ:RELVReliv International Stock Price, Forecast & News

+0.14 (+3.35 %)
(As of 05/25/2020 04:00 PM ET)
Today's Range
Now: $4.32
50-Day Range
MA: $3.27
52-Week Range
Now: $4.32
Volume32,200 shs
Average Volume27,071 shs
Market Capitalization$7.54 million
P/E RatioN/A
Dividend YieldN/A
Reliv' International, Inc. develops, manufactures, and markets nutritional supplements that address basic nutrition, wellness needs, weight management, and sports nutrition. Its nutritional supplements primarily include Reliv Classic and Reliv NOW, which are basic nutritional supplements containing a balanced blend of vitamins, minerals, proteins, and herbs; Innergize!, an isotonic sports supplement in two flavors; FibRestore, a high-fiber and antioxidant supplement; and LunaRich X, a soy concentrate with elevated levels of lunasin in capsule form. The company markets and sells its products through a network of distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, Singapore, and the United Kingdom. Reliv' International, Inc. was founded in 1984 and is headquartered in Chesterfield, Missouri.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.67 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
SectorConsumer Staples
Current SymbolNASDAQ:RELV



Sales & Book Value

Annual Sales$35.06 million
Cash Flow$0.08 per share
Book Value$6.36 per share


Net Income$-440,000.00


Market Cap$7.54 million
Next Earnings Date8/14/2020 (Estimated)
OptionableNot Optionable

Receive RELV News and Ratings via Email

Sign-up to receive the latest news and ratings for RELV and its competitors with MarketBeat's FREE daily newsletter.

Reliv International (NASDAQ:RELV) Frequently Asked Questions

How has Reliv International's stock been impacted by COVID-19 (Coronavirus)?

Reliv International's stock was trading at $3.25 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, RELV stock has increased by 32.9% and is now trading at $4.32. View which stocks have been most impacted by Coronavirus.

When is Reliv International's next earnings date?

Reliv International is scheduled to release its next quarterly earnings announcement on Friday, August 14th 2020. View our earnings forecast for Reliv International.

How were Reliv International's earnings last quarter?

Reliv International, Inc (NASDAQ:RELV) released its earnings results on Friday, May, 15th. The company reported $0.38 EPS for the quarter. The business had revenue of $10.28 million for the quarter. Reliv International had a negative net margin of 1.13% and a negative return on equity of 3.52%. View Reliv International's earnings history.

Has Reliv International been receiving favorable news coverage?

News headlines about RELV stock have been trending very negative this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Reliv International earned a daily sentiment score of -3.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutReliv International.

Are investors shorting Reliv International?

Reliv International saw a decrease in short interest in May. As of May 15th, there was short interest totaling 100 shares, a decrease of 66.7% from the April 30th total of 300 shares. Based on an average trading volume of 3,000 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the shares of the company are short sold. View Reliv International's Current Options Chain.

Who are some of Reliv International's key competitors?

What other stocks do shareholders of Reliv International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Reliv International investors own include NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Gold Standard Ventures (GSV), Gold Standard Ventures (GSV), Primo Water (PRMW), Rite Aid (RAD), RadNet (RDNT), Ring Energy (REI), Ring Energy (REI) and VIVUS (VVUS).

Who are Reliv International's key executives?

Reliv International's management team includes the following people:
  • Mr. Robert L. Montgomery, Co-Founder & Chairman (Age 77)
  • Dr. Carl W. Hastings, Vice Chairman, Chief Scientific Officer & Member of the Scientific Advisory Board (Age 77)
  • Mr. Thomas W. Pinnock III, Pres of Sales & Marketing (Age 68)
  • Mr. Ryan A. Montgomery, CEO, Pres & Director (Age 45)
  • Mr. Steven D. Albright CPA, Sr. VP & CFO (Age 57)

What is Reliv International's stock symbol?

Reliv International trades on the NASDAQ under the ticker symbol "RELV."

How do I buy shares of Reliv International?

Shares of RELV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Reliv International's stock price today?

One share of RELV stock can currently be purchased for approximately $4.32.

How big of a company is Reliv International?

Reliv International has a market capitalization of $7.54 million and generates $35.06 million in revenue each year. Reliv International employs 156 workers across the globe.

What is Reliv International's official website?

The official website for Reliv International is www.reliv.com.

How can I contact Reliv International?

Reliv International's mailing address is 136 CHESTERFIELD INDUSTRIAL BLVD, CHESTERFIELD MO, 63006. The company can be reached via phone at 636-537-9715 or via email at [email protected]

This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.